Markets
Batman and Robin Superhero Postage Stamp
Getty Images
NAMING RIGHTS

From FANG to BATMMAAN, BRICS to PIGS — why investors obsess over acronyms and monikers

Finance can be kind of boring, so we make stuff up about GRANOLAS and BATs to make it fun. How long those acronyms are useful depends on the markets.

David Crowther

Few industries love an acronym more than finance. Some are warranted: EBITDA, a measure of profit, would be a pain to write out in full every time. Some of them, like BRICs — a term coined by Goldman Sachs economist Jim O’Neill in 2001 to refer to the fast-growing economies of Brazil, Russia, India, and China — or the once debt-laden PIGs — Portugal, Italy, Greece, and Spain — become focal points for debates about the future shape of the global economy. Others, like FOMO (fear of missing out) or YOLO (you only live once), get hijacked and become verbs used by traders to explain their insane bets.

FANG > MAGMA > MAG 7 > BATMMAAN

In 2020, back when Meta was still Facebook and Big Tech was big instead of colossally massive, I tried to coin the term FAATMAN with a chart that looked a bit like a ransom note. It didn’t catch on like the Magnificent 7 (or Mag 7) did. C’est la vie.

But last week, America’s second largest chipmaker, Broadcom, soared on the back of strong earnings. With the company’s CEO talking up the opportunity in AI, the company’s stock climbed over $215 a share — bringing Broadcom into the exclusive trillion-dollar market-cap club, America’s eighth public company to currently hold that badge of honor.

With Broadcom now a bona fide stock-market stud, I wondered whether it might open up some new mnemonic madness. So I sat down on my sofa playing Scrabble in my head. A few minutes later, it hit me: BATMMAAN. Would it would work? I pinged our newsroom to check my spelling, and confirmed that even with Broadcom’s ticker confusingly being AVGO — a relic from when Avago Technologies Limited acquired Broadcom in 2016 — I could finally make my modest offering to the history of goofy stock-market buzzwords.

But the shelf-life of wacky acronyms or monikers is generally short, with none outlasting the relevance of their components, and BATMMAAN will be no different.

In the 1960s and 1970s there was the Nifty Fifty, an informal group of ~50 US stocks that were the foundation of “buy and hold” portfolios for investors looking to invest in blue-chip names. The nickname lost a little luster when the markets turned sharply at the beginning of 1973 and faded over the following decade as the 50 fell out of favor.

A similar fate befell FANG (Facebook, Amazon, Netflix, and Google) arguably the original Big Tech acronym, coined by Bob Lang and popularized by Jim Cramer on the CNBC show Mad Money. Netflix had been a rocket, but in terms of scale it didn’t match up to the rest of tech. Even after a phenomenal 2024 (gaining 92%), Netflix’s market cap is only $385 billion, just over one-tenth of Apple’s. And so FANG gave way to FAANG, and then a flood of other initialisms — FAAMG, MANTAMAN, MAMAA, and more — came and went. Analysts have espoused the wonders of the GRANOLAS stocks in Europe and the Asian tech giants of Baidu, Alibaba, and Tencent, which were the original BAT stocks.

Catchy acronyms work because we all want something easy to remember, a catchphrase we can call back to quickly. But whether BATMMAAN has longevity will depend on how relevant those names remain, and whether the voracious appetite for high-growth, sometimes volatile, tech companies persists. 

But at the moment, these eight stocks — Broadcom, Apple, Tesla, Microsoft, Meta, Amazon, Alphabet, and Nvidia — are the mass at the center of the market:

BATMMAAN stocks
Sherwood News

They’ve gained $6.2 trillion in market cap this year, represent 12% of the S&P 500’s revenue, 26% of its profit, and 34% of its weighting — but most crucially of all, each of them in their own way is tightly wrapped up with the stock-market theme of the moment, artificial intelligence, such that anyone seeking to invest in AI would be making a very bold call to ignore those stocks. To borrow from another finance acronym, born during the zero-interest-rate era, TINA: there is no alternative to these eight companies. For now.

More Markets

See all Markets
markets

Nike’s China business declines for seventh straight quarter, stock sinks as soft guidance outweighs Q3 earnings beat

Sportswear kingpin Nike reported results for its third quarter, which ended in February, after the bell Tuesday. At a headline-level, the fiscal Q3 numbers were pretty solid, with Nike reporting:

  • Earnings of $0.35 per share, comfortably above the Wall Street consensus of $0.29 per share compiled by FactSet.

  • $11.28 billion in total revenue, roughly in line with the $11.26 billion estimate.

However, weakness in China and a revenue forecast that implies sales will continue to drop are weighing on the shares, which are down more than 9% in early trading on Wednesday.

On the earnings call, management said that revenue is expected to drop 2% to 4% in the coming quarter, and that overall they "expect revenues to be down low-single-digits versus the prior year, with gains in North America offset by declines in Greater China." That's a disappointment to analysts, who were anticipating 2% growth in the coming quarter, and even more in the latter stages of the year, per Bloomberg.

Nike’s sales in China — where the company earns about 15% of its revenue — fell 7% to $1.62 billion. That’s its seventh straight quarter of sales declines in the market, though this quarter’s was less than feared. The company had issued weak guidance for this quarter considering continued softness in the region.

“This quarter we took meaningful actions to improve the health and quality of our business,” said Nike CEO Elliott Hill. “The pace of progress is different across the portfolio and the areas we prioritized first continue to drive momentum.”

Nike shares are trading near decade lows this month, as tariffs continue to weigh on profits and shipping costs rise amid the war with Iran. As of Tuesday’s close, the stock was down 17% year to date.

Oil-sensitive travel stocks pop following Iran state media reporting on potential war resolution

Travel stocks are surging on Tuesday as oil prices fall following reports from Iranian state media that President Masoud Pezeshkian said the country has the necessary will to end this war, but would only do so with guarantees that prevent the recurrence of aggression.

The war has sent oil prices and refining margins surging this month, causing airlines and cruise lines to cut profit forecasts despite reported high demand.

Following Tuesday’s update, shares of the big four US airlines (Delta Air Lines, United Airlines, American Airlines, and Southwest Airlines) all climbed, along with smaller rivals including JetBlue. US airlines have stopped fuel hedging in recent years, increasing their exposure to upward swings in oil prices.

Cruise stocks also rallied, with Carnival and Norwegian up more than 6% and Royal Caribbean up about 5%.

markets

The FDA is expected to lift restrictions on certain peptides, the NYT reports

The Food and Drug Administration is expected to lift restrictions on certain peptides, allowing the experimental, often injectable substances to be sold by compounding pharmacies, The New York Times reported Tuesday.

The potential move was previously reported by The Wall Street Journal, and teased by Health Secretary Robert F. Kennedy Jr. on the “Joe Rogan Experience” podcast in late February.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

markets

Memory stocks bounce as Bernstein analyst calls TurboQuant fears “overdone”

Memory stocks rose Tuesday, after Bernstein analysts called the recent panic over Google’s TurboQuant AI algorithm “overdone.”

Bernstein analyst Mark Newman wrote:

“[Hard disk drive] and Memory stocks have sold off significantly due in part to fears from Google’s TurboQuant report. This however, should have zero impact on HDD demand and negligible impact on NAND demand. Given the stock sell-off we see this as an attractive entry point for Seagate Technology Holdings, Western Digital and Sandisk’s and upgrade WDC to Outperform.”

All three stocks were up early Tuesday, as was memory chip maker Micron.

Todays rally stands in stark contrast to the pummeling these shares have endured over the last week, after Google Research published a technical paper on March 24 detailing its TurboQuant AI algorithm, which compresses the amount of data associated with AI operations without affecting the accuracy of AI models.

That was seen as a threat to surging AI demand for memory storage, which has supercharged prices for memory chips and memory-related stocks over the last year.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.